May 2016

More than two-thirds of CEOs at the largest medical device companies saw their total compensation go up during their companies’ most recent fiscal years, with average total compensation rising more than half a million dollars, to nearly $8.7 million.

Qmed analyzed the most recent proxy statements of 38 large medtech companies that are publicly traded in the U.S.

Download the full spreadsheet today.